Specimen Validity Edge Nona Scientific's patented specimen validity testing sets it apart as one of the few reference labs offering anti subversion capabilities, making it a strong candidate for clinics, rehab centers, and health systems seeking fraud resistant results. Consider targeting large multi site providers with centralized testing needs and dedicated anti fraud workflows.

Market Expansion With nationwide service and a focused offering in urine toxicology and confirmations, there is an opportunity to pursue enterprise level partnerships with health systems and employer based drug testing programs, offering standardized panels, service level agreements, and bulk pricing.

Product Leadership The launch of NonaClear 2.0 demonstrates ongoing innovation to detect synthetic urine and subversion methods; position as a platform for upgrading clients and preempting regulatory changes requiring robust specimen validity.

Leadership Momentum Appointment of Robb Chapin as Chairman of Advisory Board signals stronger industry credibility and networking potential; leverage the advisory board to open new enterprise relationships and strategic alliances.

Scale Opportunities As a smaller lab with a growth oriented profile there is room to offer white label testing, tighter LIMS integration, and managed services to health systems seeking turn key laboratory partnerships, enabling faster scale with existing clients.